New technique opens the door to safer gene editing by reducing the mutation problem in gene therapy

by

CRISPR-Cas9 is widely used to edit the genome by studying genes of interest and modifying disease-associated genes. However, this process is associated with side effects including unwanted mutations and toxicity. Therefore, a new technology that reduces these side effects is needed to improve its usefulness in industry and medicine.

Leave A Comment

Your email address will not be published. Required fields are marked *